Prevalence and patterns of breast white adipose tissue inflammation among American Black women and indigenous Nigerian women with early-stage breast cancer.

Authors

null

Bethina Liu

Weill Cornell Medical Center, New York, NY

Bethina Liu , Sherry Shen , Oluwatosin Zainab Omoyiola , Oluwole O. Odujoko , Avinash Sharma , Gbenga Samson Ogunleye , Israel Adeyemi Owoade , Olalekan Olasehinde , Funmilola Olanike Wuraola , Peter Ntiamoah , Jessica Flynn , Yuan Chen , Dilip D. Giri , Andrea Carpio , Rivka Kahn , Cassandra Chang , Monica Morrow , Olusegun Isaac Alatise , T. Peter Kingham , Neil M. Iyengar

Organizations

Weill Cornell Medical Center, New York, NY, Memorial Sloan Kettering Cancer Center, New York, NY, Obafemi Awolowo University, Ile Ife, Nigeria, Dept. of Anatomy and Pathology, Ile-Ife, Nigeria, Department of Surgery, Ile-Ife, Nigeria, African Research Group for Oncology, Ile-Ife, Nigeria, Department of Surgery, College of Health Sciences, Obafemi Awolowo University, Ile Ife, Nigeria, OAUTHC, Ile-Ife, Nigeria, Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, OAUTHC, Abuja, Nigeria

Research Funding

Other Foundation
Breast Cancer Research Foundation

Background: Racial disparities in breast cancer outcomes pose a major public health challenge. Complex interactions between social determinants of health and tumor biology, mediated by obesity and adiposity, may play an important role in these disparities. White adipose tissue inflammation (WATi) of the breast, which is histologically defined by the presence of crown-like structures (CLS-B), occurs in the setting of excess adiposity and promotes tumor growth via elevated levels of aromatase, proinflammatory growth factors, and metabolic dysregulation. Here we examined relationships between race, body mass index (BMI), and WATi in two cohorts of patients with early-stage breast cancer: 1) American Black women and 2) indigenous Nigerian women. Methods: Non-tumor breast WAT specimens were collected from patients undergoing mastectomy for treatment or prevention of breast cancer at Memorial Sloan Kettering Cancer Center (MSK) in the US and Obafemi Awolowo University Teaching Hospital (OAUTH) in Nigeria. WATi was defined by the presence of CLS-B as detected by CD68 immunostaining. All tissue analyses were performed at MSK. Associations among BMI and WATi were tested within each cohort using Kendall’s tau rank correlation and compared between cohorts using Pearson's Chi-squared test. Results: A total of 224 American women were enrolled at MSK between 2011-2018, of whom 39 self-reported Black race. At OAUTH, 97 Nigerian women were enrolled between 2018-2022. Invasive carcinoma was present in 32 American Blacks and 97 Nigerians. Of those with invasive carcinoma, the prevalence of WATi among American Black women was 72% vs. 37% in the Nigerian cohort (p<0.001). In the US cohort, there was no significant difference between the prevalence of WATi among Black vs. non-Black patients (72% vs. 62%; p=0.3). 44% of American Blacks were obese and 34% overweight compared with 27% and 39% of Nigerians, respectively (p=0.07). The prevalence of WATi varied by BMI category within each cohort, as shown. Overweight/obesity was associated with WATi in the Nigerian (p=0.009) and American cohorts (p<0.001); a trend was observed in the American Black subgroup (p=0.13). Conclusions: Breast WATi and obesity were more prevalent among American Black women with breast cancer compared with Nigerian women. These findings highlight the need for further investigation of environment, lifestyle patterns, and body composition differences between indigenous and diaspora populations.

Prevalence of WATi among Black women with early-stage invasive breast carcinoma by BMI.

US cohort (n = 32)Nigerian cohort (n = 97)
BMI categoryCLS-B presentp-value1CLS-B presentp-value1
Normal: <254 (57%)0.137 (21%)0.009
Overweight: 25-29.97 (64%)15 (39%)
Obese: ≥3012 (86%)14 (54%)

1Kendall’s rank correlation tau.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2023 ASCO Annual Meeting

Session Type

Publication Only

Session Title

Publication Only: Breast Cancer—Local/Regional/Adjuvant

Track

Breast Cancer

Sub Track

Biologic Correlates

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr e12560)

DOI

10.1200/JCO.2023.41.16_suppl.e12560

Abstract #

e12560

Abstract Disclosures

Similar Abstracts